Signaling pathway models as biomarkers: Patient-specific simulations of JNK 
activity predict the survival of neuroblastoma patients

Fey, Dirk; Halasz, Melinda; Dreidax, Daniel; Kennedy, Sean P.; Hastings, Jordan F.; Rauch, Nora; Munoz, Amaya Garcia; Pilkington, Ruth; Fischer, Matthias; Westermann, Frank; Kolch, Walter; Kholodenko, Boris N.; Croucher, David R.

doi:10.1126/scisignal.aab0990

Lokale TagsFreigabegeschichteDetailsÜbersicht

Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients

Fey, D., Halasz, M., Dreidax, D., Kennedy, S. P., Hastings, J. F., Rauch, N., et al. (2015). Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients. Science Signaling, 8(408): ra130. doi:10.1126/scisignal.aab0990.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0029-5BEB-5 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-002A-3E0D-3

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Fey, Dirk, Autor
Halasz, Melinda, Autor
Dreidax, Daniel, Autor
Kennedy, Sean P., Autor
Hastings, Jordan F., Autor
Rauch, Nora, Autor
Munoz, Amaya Garcia, Autor
Pilkington, Ruth, Autor
Fischer, Matthias¹, Autor
Westermann, Frank, Autor
Kolch, Walter, Autor
Kholodenko, Boris N., Autor
Croucher, David R., Autor

Affiliations:
1Neuronal Control of Metabolism, Department Jens Brüning, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149644